Skip to main content

Table 1 Outcome variables, measurement tools and assessment schedule

From: Program of rehabilitative exercise and education to avert vascular events after non-disabling stroke or transient ischemic attack (PREVENT Trial): a multi-centred, randomised controlled trial

Variable

Measurement tool

Baseline

Post-intervention

6-month follow-up

12-month follow-up

Primary measures

     

Blood pressure

Sphygmomanometer [67]

√

√

√

√

Waist girth

Tape measure [68]

√

√

√

√

Lipid profile*

Biochemical analysis

√

√

√

√

Fasting serum glucose

Biochemical analysis

√

√

√

√

Haemoglobin A1c

Biochemical analysis

√

√

√

√

Secondary measures

     

Aerobic fitness

Peak VO2 using maximal treadmill stress test (ramp protocol)

√

√

 

√

Lower extremity function

Short Physical Performance Test [69]

√

√

√

√

Walking endurance

Six-Minute Walk Test [70]

√

√

√

√

Physical activity

Step Watchâ„¢accelerometers

√

√

 

√

 

International Physical Activity Questionnaire [71]

√

√

√

√

Fatigue levels

Fatigue Assessment Scale [72]

√

√

√

√

Cognition

Montreal Cognitive Assessment [73]

√

  

√

Mental health

Hospital Anxiety and Depression Scale [74]

√

√

√

√

Quality of sleep

Pittsburg Sleep Quality Index [75]

√

√

√

√

Tobacco use

Self-report, using a health passport

√

√

√

√

Health care utilization

Self-report, using a health passport

√

√

√

√

Medication adherence

Self-report, using a health passport

√

√

√

√

Health-related quality

of life

Medical Outcomes Study Short-form 36-item Questionnaire [76]

√

√

 

√

Health-related goals

Goal Attainment Scaling [77]

√

√

√

√

Secondary vascular events**

Health record abstraction

√

√

√

√

  1. *Includes total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides
  2. **Includes second stroke, second TIA, acute coronary syndrome (i.e., unstable angina and myocardial infarction), heart failure, and vascular death